Twist Bioscience (TWST) Stock
Fundamentals
Compare with TWST
Recent news

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
TWST

Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
TWST

3 Analysts, 3 Trades to Make Today
3 Analysts, 3 Trades to Make Today
TWST

Why Twist Bioscience Stock Skyrocketed This Week
Why Twist Bioscience Stock Skyrocketed This Week
TWST
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 52.21
- MACD 12/26/9
- 15.08
- EMA 9 of MACD
- 14.61
- MACD histogram
- 0.46
- SMA 50
- $139.62
- Price above SMA 50
- EMA 50
- $144.29
- Price above EMA 50
- SMA 200
- $78.60
- Price above SMA 200
- EMA 200
- $87.64
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 6, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 7 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of -$0.37 for this quarter. The company has not yet shared when it is announcing earnings.
Latest news

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
TWST

Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
TWST

3 Analysts, 3 Trades to Make Today
3 Analysts, 3 Trades to Make Today
TWST

Why Twist Bioscience Stock Skyrocketed This Week
Why Twist Bioscience Stock Skyrocketed This Week
TWST

TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short
TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short
TWST

HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?
HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?
TWST

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
TWST

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
TWST

SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future
SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future
TWST

‘Pharma Bro’ Martin Shkreli Slams Anthropic’s Claude Drug-Discovery Claims: ‘This Is Not Impressive Work’
‘Pharma Bro’ Martin Shkreli Slams Anthropic’s Claude Drug-Discovery Claims: ‘This Is Not Impressive Work’
TWST
News tone: automated (AI) classification of the article's content, not a price prediction.
About Twist Bioscience
At Twist Bioscience, we work in the service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Emily Marine Leproust Ph.D. | Co-Founder, Board Chair & CEO | 1973 |
| Dr. Patrick John Finn Ph.D. | President & COO | 1972 |
| Mr. Adam Laponis | Chief Financial Officer | 1977 |
| Mr. Dennis Cho J.D. | Chief Legal Officer & Corporate Secretary | 1971 |
| Ms. Paula Green | Senior Vice President of Human Resources | 1968 |
| Mr. Robert F. Werner | VP & Chief Accounting Officer | 1973 |
| Mr. Siyuan Chen | Chief Technology Officer | — |
| Dr. Michael Fero Ph.D. | Chief Information Officer | — |
| Dr. Colby Souders Ph.D. | Chief Scientific Officer | — |
| Ms. Nicole Moreno | Senior Vice President of Sales & Support | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Technical indicators
- RSI 14
- 52.21
- MACD 12/26/9
- 15.08
- EMA 9 of MACD
- 14.61
- MACD histogram
- 0.46
- SMA 50
- $139.62
- Price above SMA 50
- EMA 50
- $144.29
- Price above EMA 50
- SMA 200
- $78.60
- Price above SMA 200
- EMA 200
- $87.64
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 6, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $45.00
- Average
- $134.43
- High
- $212.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +20.5 | -24.7 | -11.1 | |||||||||
| 2022 | -28.6 | -10.3 | -11.0 | -45.5 | +8.6 | +13.1 | +18.0 | -10.1 | -12.9 | -9.0 | -19.0 | -14.5 |
| 2023 | +20.5 | -33.1 | -17.6 | -11.4 | +22.5 | +27.8 | +22.6 | -3.9 | -14.0 | -17.8 | +54.0 | +48.7 |
| 2024 | -6.5 | +18.1 | -11.8 | -9.2 | +31.1 | +12.0 | +14.1 | -18.5 | +10.3 | -7.0 | +18.3 | -7.6 |
| 2025 | +15.6 | -26.4 | +5.8 | -1.6 | -22.3 | +18.4 | -8.7 | -19.9 | +7.2 | +12.4 | +1.4 | +6.2 |
| 2026 | +26.8 | +0.2 | +3.6 | +18.0 | +10.7 | +51.6 | -10.5 | +37.5 | +46.3 | -11.2 |



